CN |CAS  
 
  Home | Links | Site map
 
Home About Us News Organization Research Faculty Publication Education&Trainning Contact
  About Us
Location: Home > About Us > History
 
History
Brief Introduction
History
Address from the Director
Directors
Administration
Achievements
International Cooperation
The brief history of Shanghai Institute of Materia Medica
Update time: 2009-07-15
Close
Text Size: A A A
Print

  

Shanghai Institute of Meteria Medica was evolved from Peking Institute of Materia Medica, Academia Sinica, which was founded in the summer of 1932 by Prof. Zhao Chenggu. However, the political situation was volatile at that time, Peking Institute of Materia Medica was forced to be relocated to Franco-Chinois de Shanghai first and then toWukang Road,Shanghai in 1936.

Follow the foundation of a new China, the institute was acquired by the Chinese Academy of Sciences and named as Shanghai Institute of Materia Medica (SIMM). In 1958, it was moved to 320, Yueyang Road where it stayed for about 45 years.

After 1956, SIMM directed its focus on the discovery of novel therapeutics for schistosomiasis, hypertension and cancer. It was also involved in new antibiotics development. SIMM played a key role in China’s efforts in new drug research.

In the 1960s, SIMM was focused on the promotion of its research outcome and developed several important new drugs, such as tetrahydropalmatine, galanthamine, nystain, etc. 

After the‘Culture Revolution’, SIMM opened a new chapter in its academic research and reorganized the structure to include eight departments (synthetic chemistry, natural product chemistry, antibiotics, pharmacology, analytical chemistry, etc.) and one pilot production plant.

In the 1980s, SIMM intensified its basic and applied research activities in order to expedite various natural product chemistry programs. At that period, SIMM was in charge of a number of national key initiatives and the 863 projects. As a result, significant achievements were made including the completion of the ‘Pilot production of penicillin acylase mycophenolate by genetic engineering’, ‘Development of Dimercaptosuccinic acid disodium sult’ and "The total synthesis of Maytansine".

In the 1990sSIMM developed a comprehensive R&D strategy, thereby directing its research focus towards natural product chemistry, medicinal chemistry, pharmacology, toxicology, drug design, etc. 

In May, 2003, Shanghai Institute of Materia Medica was relocated to Zhangjiang High-tech Park, and has entered a new development phase unprecedented in its history.                       

 

weimoban
About Us News Research Faculty Education&Trainning Organization Contact
Brief Introduction
History
Address from the Director
Directors
Administration
Research
Events
Int'l cooperation
Target
Discovery
Development
Translation
Academician
PI
Graduate Students
Post Graduate Students